SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-018495
Filing Date
2020-04-24
Accepted
2020-04-24 16:09:49
Documents
6
Period of Report
2020-06-11
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A crsp-def14a_20200611.htm DEF 14A 2391994
2 GRAPHIC gmkgfhjdl5g2000002.jpg GRAPHIC 3053
3 GRAPHIC gmkgfhjdl5g2000004.jpg GRAPHIC 72086
4 GRAPHIC gmkgfhjdl5g2000001.jpg GRAPHIC 4427
5 GRAPHIC gmkgfhjdl5g2000003.jpg GRAPHIC 69300
6 GRAPHIC gmkgfhjdl5g2000005.jpg GRAPHIC 23002
  Complete submission text file 0001564590-20-018495.txt   2630406
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37923 | Film No.: 20815041
SIC: 2836 Biological Products, (No Diagnostic Substances)